Lamivudine
Product Images NDC 10135-605

4 FDA label images from Marlex Pharmaceuticals Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 10135-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamivudine Usp (also Known As 3tc), A Synthetic Nucleoside Analogue With Activity Against Hiv-1 And Hbv. The Chemical Name Of Lamivudine Is (2r,cis)-4- Amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)- (1h)-pyrimidin-2-one. Lamivudine Is The (-)enantiomer Of A Dideoxy Analogue Of Cytidine. Lamivudine Has Also Been Referred To As (-)2′,3′- Dideoxy, 3′-thiacytidine. It Has A Molecular Formula Of C8h11n3o3s And A Molecular Weight Of 229.3. It Has The Following Structural Formula: (Lamivudine 01)

Lamivudine Usp (also Known As 3tc), A Synthetic Nucleoside Analogue With Activity Against Hiv-1 And Hbv. The Chemical Name Of Lamivudine Is (2r,cis)-4- Amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)- (1h)-pyrimidin-2-one. Lamivudine Is The (-)enantiomer Of A Dideoxy Analogue Of Cytidine. Lamivudine Has Also Been Referred To As (-)2′,3′- Dideoxy, 3′-thiacytidine. It Has A Molecular Formula Of C8h11n3o3s And A Molecular Weight Of 229.3. It Has The Following Structural Formula: (Lamivudine 01)
Chemical structure diagram of the active ingredient Lamivudine, showing its molecular components including nitrogenous bases and sugar-like moiety with specific bond arrangements.*
FDA Label Image

Figure 1. Systemic Clearance (l/hr•kg) Of Lamivudine In Relation To (Lamivudine 02)

Figure 1. Systemic Clearance (l/hr•kg) Of Lamivudine In Relation To (Lamivudine 02)
A line graph depicting systemic clearance as a function of age in years. The y-axis represents systemic clearance ranging from 0.0 to 1.2, and the x-axis shows age from 0 to 60 years. The curve shows a decline in systemic clearance with increasing age, leveling off around age 30.*
FDA Label Image

Figure 2. Virologic Response Through Week 48, Epv20001 (intent-to-treat) (Lamivudine 03)

Figure 2. Virologic Response Through Week 48, Epv20001 (intent-to-treat) (Lamivudine 03)
A line graph depicting the proportions of patients with HIV-1 RNA below 400 copies/mL over a 48-week treatment period, comparing Lamivudine 150 mg twice daily and Lamivudine 300 mg once daily dosing regimens.*
FDA Label Image

Principal Display Panelndc 10135-0605-71marlexlamivudineoral Solution, Usp10 mg Per 1 mLrx Only240 mL ( 8 Ounces) (Lamivudine 04)

Principal Display Panelndc 10135-0605-71marlexlamivudineoral Solution, Usp10 mg Per 1 mLrx Only240 mL ( 8 Ounces) (Lamivudine 04)
Label for Lamivudine Oral Solution, USP by Marlex Pharmaceuticals Inc, in a 240 mL (8 ounces) bottle. The solution strength is 10 mg per 1 mL, containing 5% alcohol by volume. The label includes storage instructions, dosage reference, a barcode, and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.